Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biliary carcinoma associated with methyldopa therapy

G Brodén, L Bengtsson

    Acta Chirurgica Scandinavica. Supplementum
    |January 1, 1980
    PubMed
    Summary

    A study found a higher prevalence of methyldopa therapy in biliary carcinoma patients. Researchers discuss how methyldopa

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Spatially disaggregated population estimates in the absence of national population and housing census data.

    Proceedings of the National Academy of Sciences of the United States of America·2018
    Same author

    Exploring the high-resolution mapping of gender-disaggregated development indicators.

    Journal of the Royal Society, Interface·2017
    Same author

    TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression.

    Oncogene·2016
    Same author

    A microcomputer model of contaminant transport in an aquatic system.

    Environmental monitoring and assessment·2013
    Same author

    Predominant bacterial species in subgingival plaque in dogs.

    Journal of periodontal research·2011
    Same author

    Wound-related pain is underestimated in patients with diabetic foot ulcers.

    Journal of wound care·2008

    Area of Science:

    • Oncology
    • Pharmacology
    • Hepatology

    Background:

    • Biliary carcinoma presents a significant health challenge.
    • Understanding potential environmental and therapeutic risk factors is crucial for prevention and treatment.
    • Methyldopa is a medication with a known metabolic pathway.

    Purpose of the Study:

    • To investigate the prevalence of methyldopa use in patients diagnosed with biliary carcinoma.
    • To explore the potential role of methyldopa in the development of biliary tract cancers.

    Main Methods:

    • Retrospective analysis of 82 patients with biliary carcinoma.
    • Review of patient medical histories to identify medication use, specifically methyldopa.
    • Discussion of the biochemical mechanisms of drug-induced carcinogenesis.

    Main Results:

    • A higher than anticipated prevalence of methyldopa therapy was observed among the studied biliary carcinoma patients.
    • This finding suggests a potential association between methyldopa exposure and biliary cancer development.

    Conclusions:

    • The observed association warrants further investigation into methyldopa's potential carcinogenicity.
    • Electrophilic reactive metabolites of methyldopa may play a role in the carcinogenesis of biliary carcinoma.
    • Future research should focus on prospective studies and mechanistic investigations.

    Related Experiment Videos